Table 2.
Hazard Ratios and 95% Confidence Intervals for All-Cause, Cardiovascular Disease, and Cancer Mortality Associated With a Decrease in Hormone Level Equal to the Difference Between the 90th and 10th Percentilesa for Follow-up Between Study Baseline and Year 9, NHANES III, United States, 1988–2006
| All-Cause Mortality (n =
103 Events) |
Cardiovascular Disease Mortality
(n = 42 Events) |
Cancer Mortality (n = 28
Events) |
||||
| HR | 95% CI | HR | 95% CI | HR | 95% CI | |
| Testosterone | ||||||
| Age and race-ethnicity adjusted | 0.97 | 0.61, 1.56 | 1.26 | 0.79, 2.03 | 0.42 | 0.05, 3.25 |
| Multivariable adjustedb | 1.13 | 0.73, 1.76 | 1.41 | 0.77, 2.55 | 0.89 | 0.26, 2.99 |
| Multivariable and hormone adjustedc | 1.18 | 0.68, 2.03 | 1.07 | 0.76, 1.53 | 1.08 | 0.65, 1.80 |
| Estradiol | ||||||
| Age and race-ethnicity adjusted | 1.20 | 0.69, 2.08 | 2.11 | 1.42, 3.14 | 0.54 | 0.13, 2.28 |
| Multivariable adjustedb | 1.52 | 0.99, 2.33 | 2.82 | 1.62, 4.90 | 0.96 | 0.34, 2.74 |
| Multivariable and hormone adjustedc | 1.21 | 0.72, 2.01 | 2.40 | 1.46, 3.95 | 0.97 | 0.39, 2.44 |
| AAG | ||||||
| Age and race-ethnicity adjusted | 0.67 | 0.32, 1.42 | 0.97 | 0.36, 2.64 | 0.86 | 0.38, 1.91 |
| Multivariable adjustedb | 0.60 | 0.23, 1.54 | 0.93 | 0.32, 2.75 | 0.68 | 0.21, 2.19 |
| Free testosterone | ||||||
| Age and race-ethnicity adjusted | 1.33 | 1.11, 1.59 | 1.45 | 1.13, 1.87 | 1.19 | 0.76, 1.86 |
| Multivariable adjustedb | 1.43 | 1.09, 1.87 | 1.53 | 1.05, 2.23 | 1.07 | 0.72, 1.58 |
| Bioavailable testosterone | ||||||
| Age and race-ethnicity adjusted | 1.41 | 1.19, 1.67 | 1.54 | 1.18, 2.00 | 1.31 | 0.93, 1.83 |
| Multivariable adjustedb | 1.52 | 1.15, 2.02 | 1.63 | 1.12, 2.37 | 1.12 | 0.79, 1.60 |
| Free estradiol | ||||||
| Age and race-ethnicity adjusted | 1.80 | 1.24, 2.59 | 2.51 | 1.85, 3.41 | 1.42 | 0.48, 4.21 |
| Multivariable adjustedb | 1.41 | 0.75, 2.64 | 3.22 | 2.30, 4.51 | 1.77 | 0.66, 4.71 |
| SHBG | ||||||
| Age and race-ethnicity adjusted | 0.22 | 0.07, 0.71 | 0.24 | 0.10, 0.54 | 0.13 | 0.01, 1.95 |
| Multivariable adjustedb | 0.49 | 0.17, 1.41 | 0.23 | 0.09, 0.57 | 0.26 | 0.00, 44.3 |
| Multivariable and hormone adjustedc | 0.65 | 0.24, 1.79 | 0.22 | 0.10, 0.49 | 0.21 | 0.01, 4.61 |
| Estradiol:testosterone ratio | ||||||
| Age and race-ethnicity adjusted | 1.14 | 0.73, 1.78 | 1.08 | 0.54, 2.19 | 1.48 | 0.54, 4.08 |
| Multivariable adjustedb | 1.10 | 0.65, 1.87 | 1.01 | 0.44, 2.34 | 1.08 | 0.48, 2.42 |
| Testosterone:SHBG ratio | ||||||
| Age and race-ethnicity adjusted | 1.53 | 1.25, 1.87 | 1.66 | 1.33, 2.07 | 1.45 | 1.01, 2.08 |
| Multivariable adjustedb | 1.61 | 0.97, 2.66 | 1.73 | 1.22, 2.43 | 1.51 | 1.05, 2.17 |
| Estradiol:SHBG ratio | ||||||
| Age and race-ethnicity adjusted | 3.41 | 1.92, 6.06 | 4.70 | 3.01, 7.32 | 3.19 | 0.68, 14.91 |
| Multivariable adjustedb | 1.55 | 0.66, 3.68 | 5.97 | 3.63, 9.81 | 2.83 | 0.44, 18.10 |
Abbreviations: AAG, androstanediol glucuronide; CI, confidence interval; HR, hazard ratio; NHANES III, Third National Health and Nutrition Examination Survey; SHBG, sex hormone-binding globulin.
The 10th and 90th percentile values—total testosterone: 3.2 ng/mL, 8.0 ng/mL; estradiol: 24.8 pg/mL, 52.0 pg/mL; AAG: 5.5 ng/mL, 22.9 ng/mL; free testosterone: 0.06 ng/mL, 0.16 ng/mL; bioavailable testosterone: 1.4 ng/mL, 3.9 ng/mL; free estradiol: 0.6 pg/mL, 1.4 pg/mL; SHBG: 19.8 nmol/L, 59.1 nmol/L; estradiol to testosterone ratio: 4.8, 11.7; testosterone to SHBG ratio: 0.3, 0.9; and estradiol to SHBG ratio: 1.9, 7.4.
All-cause mortality models were adjusted for age (spline), race-ethnicity (non-Hispanic white, non-Hispanic black, Mexican American, other), smoking status (never, former, current), tertile of pack-years of smoking, household income (</≥$20,000), education (</≥high school), alcohol consumption (</≥1 drink a week), exercise (none/1–2/≥3 times a week), and percent body fat (continuous). Cardiovascular disease and cancer mortality models were adjusted for age (spline), race-ethnicity (non-Hispanic white, non-Hispanic black, Mexican American, other), smoking status (never, former, current), tertile of pack-years of smoking, and percent body fat (continuous).
Models for testosterone, estradiol, and SHBG were further mutually adjusted.